Annulent
A research-operations workspace for academic medical centers that links grant, ethics-review, protocol, budget, and cohort-feasibility evidence while leaving every approval and clinical decision with its accountable owner.
Established research-administration suites already combine grants and institutional review workflows, so Annulent's proposed wedge is the governed link to real-world cohort feasibility and clinical data standards. Grant draft, institutional submission, ethics finding, protocol approval, cohort query, feasibility estimate, investigator decision, participant contact, consent, enrollment, budget authorization, and study outcome remain separate.
A research administration, clinical research, informatics, grants, or finance leader at an academic medical center or integrated delivery network with multiple siloed systems. Exact role, budget, study volume, replacement appetite, and incumbent contract remain incomplete.
Common protocol, budget, evidence, and query patterns are reusable, while institution-specific configuration and review remain heavy.
Recent open phenotype-extraction activity and an incumbent interoperability gap create a current but non-decisive signal.
Research interfaces and phenotype tooling exist, but the original record verified neither interface and does not prove a newly broken barrier.
Large incumbents validate research administration, confirmed institutional interfaces enable bounded integration, and the cohort-feasibility connection offers a concrete differentiation hypothesis.
The stored score is zero. An established fused suite and a second integrated competitor weaken whitespace, the buyer is underspecified, both original interfaces were unverified, and institutional configuration, privacy, ethics, data quality, validation, change management, and replacement risk are substantial.
Discussion
No comments yet — be the first to weigh in.
